Videos

Raising Awareness Around Liver Cancer and Disease

April 9th 2021

CURE spoke with Dr. Marty T. Sellers and Dr. Laura M. Kulik, on behalf of the Blue Faery, about liver cancer and disease – its treatments, causes and areas outside of therapy.

Looking Ahead in Lung Cancer Care

April 7th 2021

Beyond Lung Cancer Treatment

April 7th 2021

Small Cell Lung Cancer

April 7th 2021

Biomarker Testing in Lung Cancer

April 7th 2021

COVID-19 and Lung Cancer

April 7th 2021

Myeloma Therapies Create an ‘Optimistic Picture’ for Patients’ Futures

April 6th 2021

In an interview, Dr. Andrew Yee of Massachusetts General Hospital discusses how a multiple myeloma diagnosis affects a patient’s life and how hopeful he is about helping them lead normal lives.

What It’s Like to Be a Myeloma Millennial, Or, ‘Myelennial’

April 5th 2021

In an interview, Dr. Nina Shah of UCSF Helen Diller Family Comprehensive Cancer Center explains what a myeloma millennial, or ‘myelennial,’ is, and how recent advances in multiple myeloma treatments inspired the term.

Why One Woman Prefers the Term ‘Cancer Alumni’ After Treatment for Lymphoma

March 30th 2021

The term “survivor” is often used to describe people who have successfully completed their cancer treatments, but Sonia Su feels like it doesn’t quite capture the complexity of what it means to be in remission.

Treating HER2+ Metastatic Breast Cancer During the COVID-19 Pandemic

March 30th 2021

Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, and Sara A. Hurvitz, M.D., discuss treatment approaches and modifications during the COVID-19 pandemic.

Adhering to Oral Therapy for HER2+ Metastatic Breast Cancer

March 30th 2021

Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, discusses the learning curve of taking an oral medication, tucatinib, in combination with chemotherapy, and Sara A. Hurvitz, M.D., reviews methods for medication adherence.

Tucatinib With Chemotherapy for HER2+ Metastatic Breast Cancer

March 30th 2021

Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, discusses how her quality of life has been since she began taking tucatinib with chemotherapy.

Advances in HER2+ Metastatic Breast Cancer

March 30th 2021

Sara A. Hurvitz, M.D., reviews the advances in HER2+ metastatic breast cancer that have been made over the past decade.

Goals of Treatment After Progression of HER2+ Metastatic Breast Cancer

March 30th 2021

Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, shares her goals of treatment after progression of disease.

Progression of HER2+ Metastatic Breast Cancer

March 30th 2021

Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, shares the hope she had after progression because of the ongoing research for HER2+ breast cancer, and Sara A. Hurvitz, M.D., reviews the drug regimens available in this realm.

‘Don’t Socially Distance Yourself’ While Going Through Cancer, Says A Survivor

March 29th 2021

Although “social distancing” has become a common term used to describe the safe distance people keep from others to avoid contracting COVID-19, stage 1 ovarian cancer survivor and teacher Brenda Kowalski reminds patients who may be starting out on their cancer journey that it’s important to not “socially distance” yourself from friends when you need support.

Understanding HER2+ Metastatic Breast Cancer

March 16th 2021

Sara A. Hurvitz, M.D., reviews the history of HER2+ breast cancer and the progressive research that has been done in this disease.

Understanding Treatment Options for HER2+ Metastatic Breast Cancer

March 16th 2021

Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, describes her experience learning about the surplus of treatment options and how she overcame her initial apprehension.

Being Diagnosed With HER2+ Metastatic Breast Cancer

March 16th 2021

Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, shares her initial impression of when she was diagnosed.

Classifying Breast Cancer

March 16th 2021

Sara A. Hurvitz, M.D., describes the subtypes, staging and grading of breast cancer.

Improving Outcomes for Patients With Brain Metastases

March 15th 2021

A Caregiver’s Perspective on Treatment Success

March 15th 2021

Feeling Supported During the Diagnosis and Treatment of Brain Metastases

March 15th 2021

Educated Patient® Multiple Myeloma Summit: March 13, 2021

March 13th 2021

View the full CURE Educated Patient Multiple Myeloma Summit on demand.

Advocates for Change: George's Story

March 10th 2021

George Valentine needs something from his elected representatives in Congress: securing predictable annual out-of-pocket costs under Medicare Part D’s prescription drug plan.

Cancer Survivor Offers Tips on How to Help Loved Ones Get Through Difficult Times

March 9th 2021

Nearly one year ago to the day, 24-year-old Nina Luker was completely blindsided by a diagnosis of non-Hodgkin lymphoma. But after powering through treatments in the thick of the COVID-19 pandemic, Luker is now cancer-free and offering advice to those who may be looking for ways to help their loved ones through difficult times of their own.

Effect of Brain Metastasis Treatment on Quality of Life

March 8th 2021

Individual Assessment of Treatment Success With Brain Metastases

March 8th 2021

Educated Patient® Breast Cancer Summit: March 7, 2021

March 7th 2021

View the full CURE Educated Patient Breast Cancer Summit on demand.

Educated Patient® Lung Cancer Summit: March 6, 2021

March 6th 2021

View the full CURE Educated Patient Lung Cancer Summit on demand.